SDEV · Stablecoin Development Corp
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | $9.78M | $10.46M | $14.4M | $10.2M | $9.93M | $6.6M | $12.51M | $18.23M | $11.9M | $4.38M | $370K | $3.25M | $6.93M | $11.02M | $9.75M | $15.68M | |
| — | — | $3.3M | $4.37M | $6.62M | $3.69M | $3.97M | $1.74M | $1.5M | $2.78M | $2.46M | $1.26M | $486K | $162K | $8000 | — | — | — | |
| — | — | $6.48M | $6.08M | $7.78M | $6.52M | $5.96M | $4.86M | $11.01M | $15.45M | $9.43M | $3.12M | $568K | $3.32M | $6000 | — | — | — | |
| — | — | 66.26% | 58.19% | 54.02% | 63.85% | 60.04% | 73.66% | 87.98% | 84.73% | 79.29% | 71.22% | 153.51% | 101.87% | 0.09% | — | — | — | |
| — | — | $42K | $34K | $174K | $44K | $285K | $184K | $259K | $410K | $1.37M | $5.73M | $9.48M | $12.46M | $9.28M | $9.91M | $8.62M | $7.34M | |
| — | — | $4.03M | $4.71M | $7.8M | $8.09M | $6.17M | $8.77M | $12.79M | $13.71M | $11.81M | $10.52M | $1.75M | — | — | — | — | — | |
| $7.73M | $7.59M | $7.38M | $5.45M | $7.49M | $7.24M | $5.93M | $5.31M | $5.83M | $8.64M | $7.24M | $8.01M | $6.24M | $45.97M | $5.97M | $5.43M | $5.65M | $5.61M | |
| — | — | — | — | — | — | — | — | — | — | — | $18.09M | $7.94M | $6.34M | $5.97M | — | — | — | |
| — | — | $152K | $152K | $363K | $60K | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | — | $51K | $120K | $59K | $51K | $65K | $266K | $95K | $114K | $164K | $232K | $314K | $341K | $425K | $427K | $373K | |
| $8M | $8.44M | $7.38M | $10.19M | $22.2M | $15.38M | $12.39M | $14.26M | $18.88M | $22.76M | $20.42M | $24.26M | $17.47M | $18.8M | $15.25M | $15.34M | $14.27M | $12.94M | |
| $17.14M | -$8.44M | -$7.38M | -$4.1M | -$14.42M | -$8.86M | -$6.43M | -$9.4M | -$7.87M | -$7.31M | -$10.98M | -$21.14M | -$16.9M | -$15.49M | -$8.31M | -$4.32M | -$4.52M | $2.74M | |
| — | — | -75.44% | -39.23% | -100.09% | -86.85% | -64.69% | -142.45% | -62.93% | -40.1% | -92.31% | -482.47% | -4568.65% | -475.91% | -119.85% | -39.21% | -46.3% | 17.47% | |
| — | — | — | -$4.05M | -$14.3M | -$8.8M | -$6.38M | -$9.34M | -$7.61M | -$7.22M | -$10.87M | -$20.97M | -$16.67M | -$15.17M | -$7.97M | -$3.9M | -$4.09M | $3.11M | |
| $533.59M | -$20K | -$581K | -$369K | -$276K | -$1.58M | $605K | -$1.43M | $19K | $12K | -$68K | $17K | $48K | $1000 | -$155K | -$30K | $258K | -$36K | |
| — | — | — | -$9.64M | -$10.61M | -$5.82M | -$11.03M | -$9.65M | -$6.54M | -$7.4M | -$13.15M | -$18.97M | -$15.19M | -$16.04M | -$7.03M | -$5.08M | -$4.26M | $2.7M | |
| $3.45M | $0 | $0 | $0 | $0 | $0 | $5000 | $6000 | $4000 | $3000 | $2000 | $2000 | $2000 | $1600 | $2000 | $2000 | $50K | $7000 | |
| -$86.05M | -$630.78M | -$7.22M | -$9.64M | -$10.61M | -$5.82M | -$11.04M | -$9.66M | -$6.55M | -$7.4M | -$13.15M | -$18.97M | -$15.19M | -$16.04M | -$7.03M | -$5.09M | -$4.31M | $2.7M | |
| — | — | -73.85% | -92.2% | -73.65% | -57.08% | -111.12% | -146.36% | -52.33% | -40.61% | -110.54% | -433.07% | -4106.49% | -492.99% | -101.36% | -46.15% | -44.17% | 17.2% | |
| -$86.05M | -$630.78M | -$8.61M | -$16.97M | -$16.27M | -$6.56M | -$11.04M | -$10.49M | -$6.55M | -$7.4M | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | -$13.15M | -$18.97M | -$15.18M | -$16.04M | -$7M | -$5.12M | -$4.32M | — | |
| USD/shares | — | -$108.39 | -$12.68 | -$695.70 | -$1,767.50 | -$920.50 | -$1,898.75 | -$2,940.00 | -$2,388.75 | -$2,940.00 | -$8,575.00 | -$41,772.50 | -$46,856.25 | -$64,373.75 | -$1,470.00 | -$1,225.00 | -$1,102.50 | $137,224,500.00 |
| USD/shares | — | — | — | — | — | — | -$1,898.75 | -$2,940.00 | -$2,817.50 | -$2,940.00 | -$8,575.00 | -$41,772.50 | -$46,856.25 | -$64,373.75 | -$1,470.00 | -$1,225.00 | -$1,102.50 | $141,579,375.00 |
| shares | — | 5.82M | 679K | 24K | 9200 | 7125.7143 | 5726.6939 | 3533.2245 | 2762.6122 | 2501.8776 | 1536 | 454.5306 | 324.0816 | 249.3061 | 4807.8367 | 4207.8367 | 3808.3265 | — |
| shares | — | — | — | — | — | 7127.6735 | 5726.6939 | 3533.2245 | 2784.9796 | 2501.8776 | 1536 | 454.5306 | 324.0816 | 249.3061 | 4807.8367 | 4207.8367 | 3808.3265 | 0.0196 |
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2018–FY2025: $4.82M in dividends.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
Peer medians compare against the 42 similar-size Asset Management companies (of 108 listed).
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2023 | FY2022 | FY2021 |
|---|---|---|---|
| Optical and Wound Care | $11,174,000 | $10,239,000 | $9,555,000 |
| Skin Care | $3,552,000 | $4,165,000 | $649,000 |
By Product & Service (USD)
| Component | FY2024 | FY2024 | FY2023 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Avenova Spray | $8,673,000 | $3,695,000 | $7,805,000 | — | $7,651,000 | $8,565,000 | $5,974,000 | $6,347,000 |
| Avenova Product | $7,200,000 | — | $6,100,000 | — | $6,500,000 | — | — | — |
| Other Products | $1,074,000 | $1,117,000 | $1,273,000 | — | $1,592,000 | $598,000 | $294,000 | $0 |
| Product And Service Other | $34,000 | $18,000 | $0 | — | $30,000 | $24,000 | $18,000 | $43,000 |
| Neutrophase | $0 | $1,043,000 | $1,377,000 | — | $976,000 | $368,000 | $524,000 | $209,000 |
| Avenova Direct | — | — | — | $1,700,000 | $6,500,000 | $6,600,000 | $3,300,000 | $1,000,000 |
| Dermadoctor | — | — | $3,552,000 | — | $4,155,000 | $649,000 | $0 | $0 |
| KN95 Masks | — | — | — | — | — | $0 | $3,124,000 | $0 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2023 | FY2022 | FY2021 |
|---|---|---|---|
| Optical and Wound Care | -$3,650,000 | -$5,645,000 | -$8,682,000 |
| Skin Care | -$3,946,000 | -$8,772,000 | -$180,000 |
Operating Margin by Segment (%)
| Component | FY2023 | FY2022 | FY2021 |
|---|---|---|---|
| Optical and Wound Care | -32.7% | -55.1% | -90.9% |
| Skin Care | -111.1% | -210.6% | -27.7% |